Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jul 21 2022

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jul-21-2022-3

Zydus Lifesciences Limited has informed the Exchange about press release dated 21-Jul-2022 titled Zydus receives final approval from the USFDA for Norepinephrine Bitartrate Injection

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases